Mettler-Toledo International (NYSE:MTD) Given New $1,700.00 Price Target at Citigroup

Mettler-Toledo International (NYSE:MTD) had its target price boosted by investment analysts at Citigroup from $1,600.00 to $1,700.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Citigroup’s price objective points to a potential upside of 18.59% from the stock’s current price.

A number of other analysts have also issued reports on the company. Bank of America lifted their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday. Barclays upped their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday. Stifel Nicolaus raised their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $1,406.50.

Mettler-Toledo International Stock Down 0.4%

Shares of MTD traded down $5.81 during mid-day trading on Monday, reaching $1,433.54. 103,394 shares of the stock traded hands, compared to its average volume of 165,431. The firm has a market cap of $29.53 billion, a price-to-earnings ratio of 36.30, a P/E/G ratio of 4.19 and a beta of 1.41. The stock has a fifty day simple moving average of $1,320.50 and a 200 day simple moving average of $1,238.16. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,454.68.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. During the same period last year, the business earned $10.21 EPS. The business’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, equities research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 165 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 1,527 shares of company stock worth $1,994,981 over the last ninety days. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. boosted its stake in shares of Mettler-Toledo International by 2.5% during the 1st quarter. Envestnet Asset Management Inc. now owns 15,823 shares of the medical instruments supplier’s stock worth $18,686,000 after acquiring an additional 393 shares in the last quarter. Cerity Partners LLC lifted its holdings in shares of Mettler-Toledo International by 7.1% during the first quarter. Cerity Partners LLC now owns 3,643 shares of the medical instruments supplier’s stock valued at $4,302,000 after purchasing an additional 242 shares during the last quarter. Ballentine Partners LLC boosted its position in shares of Mettler-Toledo International by 15.4% in the 1st quarter. Ballentine Partners LLC now owns 554 shares of the medical instruments supplier’s stock valued at $654,000 after purchasing an additional 74 shares during the period. CWM LLC raised its holdings in Mettler-Toledo International by 2.5% during the 1st quarter. CWM LLC now owns 657 shares of the medical instruments supplier’s stock worth $776,000 after buying an additional 16 shares during the period. Finally, Edgestream Partners L.P. lifted its stake in Mettler-Toledo International by 44.6% during the first quarter. Edgestream Partners L.P. now owns 8,431 shares of the medical instruments supplier’s stock valued at $9,956,000 after buying an additional 2,602 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.